Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results Feb 20, 2020 7:30am EST
Rigel Receives Positive CHMP Opinion for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe Nov 15, 2019 7:30am EST
Rigel Announces Upcoming Data Presentations at the 61st ASH Annual Meeting & Exposition Nov 07, 2019 7:30am EST
Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results Oct 29, 2019 7:30am EDT
Rigel Pharmaceuticals Provides Business Update Prior to Investor & Analyst Call Oct 23, 2019 7:30am EDT
